Thus, the presently demonstrated regulation of NF-κB activity by CFTR-β-catenin interaction may have implication in the development of GI cancer, as well as other chronic intestinal inflammatory disorders such as Crohn's disease and chronic inflammatory bowel diseases (IBD). Here, CFTR is linked to Crohn disease.